Actively Recruiting
Brain Activity During Complex Walking in People With Atypical Parkinsonian Syndromes
Led by Karolinska Institutet · Updated on 2025-07-08
30
Participants Needed
1
Research Sites
146 weeks
Total Duration
On this page
Sponsors
K
Karolinska Institutet
Lead Sponsor
K
Karolinska University Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
Every-day life means being part of a complex environment and performing complex tasks that usually involve a combination of motor and cognitive skills. However, the process of aging or the sequelae of neurological diseases such as atypical Parkinson's disease (APD) compromises motor-cognitive interaction necessary for an independent lifestyle. While motor-cognitive performance has been identified as an important goal for sustained health across different clinical populations, little is known about underlying brain function leading to these difficulties and how to best target these motor-cognitive difficulties in the context of rehabilitation and exercise interventions. The challenge of improving treatments of motor-cognitive difficulties (such as dual-tasking and navigation) is daunting, and an important step is arriving at a method that accurately portrays these impairments in an ecologically valid state. The investigators aim therefore to explore brain function during complex walking in healthy and APD by investigating the effects of age and neurological disease on motor-cognitive performance and its neural correlates during three conditions of complex walking (dual-task walking, navigation and a combination of both) using non-invasive measures of brain activity (functional near infrared spectrometry, fNIRS) and advanced gait analysis in real time in older healthy adults and people with APD.
CONDITIONS
Official Title
Brain Activity During Complex Walking in People With Atypical Parkinsonian Syndromes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Clinical diagnosis of Progressive Supranuclear Palsy (PSP) according to Movement Disorder Society (MDS) 2017 criteria or Multiple System Atrophy (MSA) according to MDS 2022 criteria
- Ability to walk continuously for 5 minutes or more, with or without a mobility device
You will not qualify if you...
- Cognitive difficulties affecting the ability to understand or follow verbal or written instructions
- Severe freezing of gait
- Severe hearing or visual impairments that affect participation
- Presence of other neurological diseases
- Other diseases that can affect gait or balance
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Karolinska Institutet
Solna, Solna, Sweden, 17177
Actively Recruiting
Research Team
C
Compliance Office Karolinska Insitutet
CONTACT
E
Erika Franzén, Prof,
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here